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E-mail: rrelich@iupui.eduBackgroundThe phylum Bacteroidetes is an extremely large and diverse
taxon composed of Gram-negative, non-sporulating, aerobic
and anaerobic, rod-shaped bacteria. Among the many members
of this phylum is the genus Pontibacter [1,2]. Members of this
genus, like most of their relatives, occupy a vast array of hab-
itats that include soil (mud and desert), marine and freshwater
environments; however, until now, human clinical isolates of
Pontibacter have not been reported [2]. Here we report the
isolation and characterization of a novel Pontibacter sp., the ﬁrst
isolate in the genus to originate from a human. This bacterium
was the sole isolate from one of four blood culture specimens
collected from a woman with apparent sepsis, who later
recovered upon treatment with broad-spectrum antimicrobial© 2017 The Authors. Published by El
This is an open access artitherapy; however, the role of this organism in the patient’s
illness is unknown. Detailed below is the clinical case descrip-
tion, details of strain isolation, and characterization of Ponti-
bacter altruii sp. nov., strain Grand Forks.Case descriptionA 72-year-old woman presented to the emergency depart-
ment of a local hospital in Grand Forks, ND, USA with
complaints of increasing shortness of breath and was noted to
be acutely confused and in respiratory and renal failure. The
patient’s past medical history was signiﬁcant for hypertension,
hyperlipidaemia, type 2 diabetes mellitus and chronic hypoxic
respiratory failure. A computed tomography scan of the pa-
tient’s torso revealed mediastinal lymphadenopathy and pul-
monary nodule enlargement, mitral valve calciﬁcation,
cholelithiasis and diffuse pulmonary interstitial thickening with
ground-glass opacities consistent with possible interstitial
pulmonary oedema secondary to congestive heart failure. A
transthoracic echocardiogram showed possible vegetations on
the mitral and tricuspid valves, but vegetations were not
apparent by trans-oesophageal echocardiogram. The patientNew Microbe and New Infect 2017; 19: 71–77
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prescribed empiric antimicrobial therapy for treatment of
suspected pneumonia. On admission, blood cultures were
collected by venipuncture and submitted in two paediatric
blood culture bottles, documented as low-volume collections;
a sputum culture was ordered, but was cancelled because a
sputum specimen could not be procured. Results of tests for
autoimmune diseases, inﬂuenza and disseminated fungal in-
fections were all negative.
Following 72 h of incubation in a continuous monitoring
blood culture system (BACTEC™ FX; BD Diagnostics, Sparks,
MD), the aerobic culture vial (BD BACTEC™ Plus Aerobic/F)
from one of two sets of blood cultures ﬂagged positive.
Microscopic examination of a Gram-stained smear of the blood
culture broth revealed pleomorphic Gram-negative rods. Ali-
quots of the blood culture broth were subcultured to solid
media, including sheep blood agar (tryptic soy agar containing
5% deﬁbrinated sheep blood), chocolate agar and MacConkey
agar (Remel, Lenexa, KS, USA). Following 24 h of incubation at
35 °C in 5% CO2, a pure culture of small, white, smooth col-
onies grew on blood and chocolate agars, but no growth was
noted on the MacConkey or other plates (Columbia CNA agar
and anaerobe cultivation media). Gram-negative rods identical
to those seen in the blood culture broth were observed in a
Gram-stained smear of the colonial growth (Fig. 1). The isolate
tested positive for cytochrome oxidase and catalase, but tested
negative for indole production using a spot indole testing pro-
cedure. Identiﬁcation of the isolate was attempted by auto-
mated (VITEK® 2 Gram-Negative Identiﬁcation card;
bioMérieux, Durham, NC, USA) and manual (API 20NE; bio-
Mérieux) phenotypic methods, and automated (VITEK® 2)
testing was performed for preliminary antimicrobial suscepti-
bility testing.FIG. 1. Gram stain of Pontibacter altruii, sp. nov. strain Grand Forks
reveals that cells are pleomorphic Gram-negative rods that vary in both
length and width. On average, cells measured 0.6 × 1.3 μm in greatest
dimension (average of 100 cells). Original magniﬁcation, 1000×.
© 2017 The Authors. Published by Elsevier Ltd on behalf of European Society of Clinical Microb
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(2000 mg on day 1, 1000 mg on day 2) and meropenem
(500 mg/8 h). The patient stabilized overnight in the intensive
care unit and was transferred to the general ward 17 h after
admission. After 2 days of antibiotic treatment, vancomycin
was discontinued due to elevated creatinine. The same day, a
rash was observed and meropenem was switched to intrave-
nous aztreonam (1 g/8 h) as the patient had a history of
penicillin allergy. Following blood culture detection, but
before susceptibility testing of the isolate, the patient also
received intravenous levoﬂoxacin (750 mg/48 h). During her
inpatient stay, the patient also received warfarin, intravenous
furosemide and bi-level positive airway pressure therapy for
prevention of thromboembolism associated with atrial ﬁbril-
lation, treatment of atrial ﬁbrillation, hypertension and respi-
ratory failure, respectively. On hospital day 17, she was
switched to oral levoﬂoxacin (750 mg/48 h for 10 days) and
discharged to home in a stable condition. Two additional sets
of blood cultures collected 1 day after the initial positive
culture remained negative. At home, the patient was ordered
to continue positive airway pressure therapy. To date, the
patient is not known to have experienced a recrudescence of
this infectious process.Materials and methodsMorphological and physicochemical analyses
Morphological attributes of this isolate, including cell shape and
size, were rendered from 1000× photomicrographs of Gram-
stained smears of colonial growth using an Olympus BX51
bright-ﬁeld microscope equipped with a DP70 12-bit digital
camera and Olympus cellSens software (Olympus, Waltham,
MA, USA). Size measurements of 100 individual cells were
made using IMAGEJ 1.X software [3] calibrated to the scale bar
attached to the photomicrographs.
Following primary isolation, the isolate was subjected to
automated phenotyping using the VITEK® 2 Gram-Negative
Identiﬁcation card following the manufacturer’s instructions
for use. Brieﬂy, colonies of the isolate were suspended in sterile
0.45% (w/v) non-bacteriostatic saline to create a cell suspension
in the range of 0.5–0.63 McFarland units. Next, the suspension
was applied, under vacuum, to a Gram-negative identiﬁcation
panel containing immobilized chromogenic substrates.
Following incubation, the biochemical proﬁle and presumptive
identiﬁcation were derived by the VITEK® 2 software. In
addition, the isolate was preliminarily identiﬁed using the API
20NE system. Characterization of the isolate using standard
tubed biochemical media was later pursued, the results of
which are listed in Table 1.iology and Infectious Diseases, NMNI, 19, 71–77
nses/by-nc-nd/4.0/).
TABLE 1. Comparison of phenotypic characteristics of the
genus Pontibacter and the proposed new species, Pontibacter
altruii, sp. nov.
Characteristics Pontibacter genus Pontibacter altruii sp. nov.
Cell shape and size Rods: 0.3–0.7
× 1.2–1.9 μm
Rods: 0.6 × 1.3 μm
Motility Gliding Gliding
Pigment production Pink, non-diffusible No pigment
Growth environment Strict aerobe Strict aerobe
Oxidase Positive Positive
Catalase Positive Positive
Alkaline phosphatase Positive Positive
Esculin hydrolysis Positive Positive
Gelatin hydrolysis Positive Positive
DNA hydrolysis Positive Positive
Nitrate reduction Negative Negative
Indole production Negative Negative
H2S production Negative Weak-positive
0% NaCl tolerance Positive Positive
Casein hydrolysis Negative NT
Tween-80 hydrolysis Negative NT
Chitin hydrolysis Negative NT
Cellulose hydrolysis Negative NT
Carbohydrate utilization Positive Dextrose: Negative
Lactose: Weak-positive
Maltose: Negative
Mannitol: Negative
Sucrose: Negative
Xylose: Negative
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Antibiotic susceptibility testing was performed using Etest
(bioMérieux) and disc diffusion; testing was performed ac-
cording to standard methods. Brieﬂy, a suspension of bacterial
colonies from a culture <24 h old were suspended in sterile
0.45% (w/v) non-bacteriostatic saline and the turbidity of the
suspension was adjusted to match a 0.5 McFarland standard.
Cation-adjusted Mueller–Hinton agar plates (150 mm; Remel,
Lenexa, KS, USA) were subsequently inoculated with the sus-
pension. When dry, either Etest strips or antibiotic-impregnated
discs were applied with forceps, and inoculated plates were
incubated at 35 °C in an ambient atmosphere for 24 h.
Nucleic acid sequencing and mass spectrometry
Total DNA was extracted from the isolate using a generic lysis
and silica adsorption-based separation protocol (NucliSENS®
EasyMAG®, bioMérieux; [4,5]). A portion of the 16S ribosomal
RNA gene was ampliﬁed with primers 27-F (50-AGAGTTT-
GATCCTGGCTCAG-30) and 1492-R (50-ACGGC-
TACCTTGTTACGACTT-30) [6] using Roche Life Science
ExpandHigh Fidelityplus reagents according to themanufacturer’s
recommendations (Roche, Basel, Switzerland). The amplicon
sequence was derived by standard dideoxy labelling methods at
the Interdisciplinary Center for Biotechnology Research (Uni-
versity of Florida). Identiﬁcation via ribosomal RNA gene
sequence was attempted by BLAST query of the National Center
for Biotechnology Information database GenBank [7,8].
Identiﬁcation of the isolate was attempted by matrix-assisted
laser desorption/ionization time-of-ﬂight (MALDI-TOF) mass© 2017 The Authors. Published by Elsevier Ltd on behal
This is an open access articspectrometry using a MALDI Biotyper instrument (Bruker-
Daltonics, Billerica, MA, USA); half of the spots were overlaid
with 70% formic acid for on-target protein extraction [9].
Brieﬂy, small portions of isolated colonies were smeared onto
six separate spots on a 96-spot stainless steel MALDI-TOF
target plate. Three of the spots were overlaid with 1 μl of
70% formic acid and allowed to completely dry. Next, all 6
spots were overlaid with 1 μl of matrix solution (α-cyano-4-
hydroxycinnamic acid), dried and analysed. Each spot was
lased 240 times to generate mass spectral proﬁles. Although
mass peaks were recorded for all spots, no identiﬁcation could
be rendered from the MALDI Biotyper research use only li-
brary (BDAL, MBT Compass, 2016).
Phylogenetic analysis
The rRNA gene sequence derived from the isolate was used to
construct a weighted neighbour-joining (‘weighbour’) tree
employing Jukes–Cantor correction (100 bootstrapped repli-
cates) [10]. The 16S rRNA gene sequence from the within-
phylum organism Bacteroides fragilis (strain Bfr920) was used
as the outgroup. The phylogenetic analysis was carried out
using the Ribosomal Database Project (RDP) platform (rdp.
cme.msu.edu) [11].ResultsClinical microbiology
After 3 days of incubation, one aerobic, paediatric vial from the
two collected grew an unknown isolate on sheep blood and
chocolate agars upon subculture. Primary phenotypic testing
provisionally identiﬁed the organism as Elizabethkingia menin-
goseptica; however, low conﬁdence scores for both VITEK® 2-
based and API 20NE-based identiﬁcations were obtained,
prompting referral of the isolate to a commercial reference
laboratory for deﬁnitive identiﬁcation. The reference labora-
tory could not provide a species-level identiﬁcation, but instead
reported the isolate’s identiﬁcation as an unidentiﬁed Gram-
negative rod, most common relative Pontibacter, based on
partial 16S rRNA gene sequencing.
Colonial characteristics
The isolate grows moderately slowly on sheep blood and
chocolate agars, but does not grow on Gram-negative selective
media, including MacConkey agar, and fails to grow in anaerobic
conditions. Pigment production, a prominent feature of other
Pontibacter spp., was not demonstrable on sheep blood and
tryptic soy agars following 7 days of incubation. Following 24 h
of incubation, colonies are small (~1 mm), smooth and glistening
(Fig. 2A). After 72 h at 35 °C, colonies reach maximum sizef of European Society of Clinical Microbiology and Infectious Diseases, NMNI, 19, 71–77
le under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
TABLE 2. Antimicrobial susceptibility testing results.
Antibiotic/testa MIC or zone of inhibition diameter
β-lactamaseb Positive
Ampicillin 0.38 μg/mL
Azithromycin 0.38 μg/mL
Aztreonam 48 mm
Cefepime 1.5 μg/mL
Ceftazidime 6 μg/mL
Ceftriaxone 8 μg/mL
Ciproﬂoxacin 0.94 μg/mL
Colistin 12 μg/mL
Doripenem 0.125 μg/mL
Ertapenem 0.064 μg/mL
Erythromycin 0.19 μg/mL
Gentamicin 128 μg/mL
Levoﬂoxacin 0.094 μg/mL
Meropenem 0.094 μg/mL
Moxiﬂoxacin 0.064 μg/mL
Penicillin G 0.50 μg/mL
Piperacillin-tazobactam 0.023 μg/mL
Rifampin 45 mm
Ticarcillin-clavulanate 0.19 μg/mL
Tigecycline 0.064 μg/mL
Tobramycin >256 μg/mL
Trimethoprim-sulfamethoxazole 0.94 μg/mL
aFor drugs other than piperacillin-tazobactam and rifampin, MICs were determined
by Etest using cation-adjusted Mueller–Hinton agar incubated in an ambient
atmosphere at 35 °C for 24 h. Haemophilus Test Medium agar was used for
piperacillin-tazobactam Etest and rifampin disc diffusion testing with incubation for
48 h at 35 °C.
bβ-lactamase testing was performed by Nitroceﬁn disc testing.
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bation, a noticeable haze of growth emanating from the colonies
is observable (Fig. 2C), and is an indication of gliding motility, a
form of motility described for other pontibacters [2]. Turbidity
is seen in broth cultures after several days of incubation.
Phenotypic characterization
The isolate exhibits all deﬁning phenotypes common to mem-
bers of the genus Pontibacter, including morphology, Gram-stain
reaction, gliding motility, strictly aerobic growth, cytochrome
oxidase and catalase production. Biochemical parameters
assessed and comparison to other Pontibacter spp. are listed in
Table 1.
Antimicrobial susceptibility testing
Antibiotic susceptibility testing demonstrated low MICs or large
zones of inhibition surrounding most agents tested, except for
the aminoglycosides amikacin, gentamicin and tobramycin
(Table 2).
Molecular characterization
The ribosomal RNA gene sequence showed 96% identity to
Pontibacter rhizosphera and 95% identity to Pontibacter korlensis.
Mass spectrum analysis of the isolate could not furnish an
identiﬁcation. The failure of both mass spectrometry and 16S
rRNA gene sequencing to deﬁnitively identify the isolate sug-
gested that it had not been previously characterized.
Phylogenetic analysis
Using weighted neighbour-joining methods, the isolate formed
its own branch within the genus Pontibacter. The deepest
branching species from the root was Pontibacter ruber, followed
by a small group containing Pontibacter deserti and Pontibacter
populi, which was followed by the novel isolate (Fig. 3).FIG. 2. Colonial morphology and growth characteristics of Pontibacter altruii
After 24 h of incubation at 35 °C in an ambient atmosphere, colonies are sma
up to 5 mm and are smooth, white and umbonate. (C) Following 96 h of incuba
indicating gliding motility.
© 2017 The Authors. Published by Elsevier Ltd on behalf of European Society of Clinical Microb
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/liceDiscussionIsolation of a novel member of the genus Pontibacter is
described. Pontibacter spp. are known to occupy diverse habitats,
but this is the ﬁrst description of a Pontibacter sp. isolated from a
human clinical specimen. Because all previous descriptions in the
literature are from environmental sources (Table 3), coupled
with the fact that this isolate was only isolated from one of four
blood culture vials, a criterion commonly used by clinical
microbiology laboratories for deﬁning blood culture contami-
nation with host microbiota, the organism’s pathogenic potential, sp. nov. strain Grand Forks grown on standard sheep blood agar. (A)
ll, smooth and white. (B) Following 72 h of incubation, colonies measure
tion, a light haze of growth is noticeable at the margin of colonies (darts)
iology and Infectious Diseases, NMNI, 19, 71–77
nses/by-nc-nd/4.0/).
FIG. 3. Phylogenetic analysis of the genus Pontibacter, including Pontibacter altruii sp. nov. A weighted neighbour-joining tree employing Jukes–Cantor
correction (100 bootstrapped replicates) was generated using 16S ribosomal RNA gene sequence from 20 previously described Pontibacter species,
P. altruii, sp. nov. and Bacteroides fragilis (outgroup). The position of P. altruii, sp. nov. (arrow) was somewhat ambiguous; however, it unambiguously
clustered within the genus rather than creating a unique lineage.
NMNI Roiko et al. Characterization of Pontibacter altruii, sp. nov. 75is unknown. In addition, direct testing of the patient’s blood for
this bacterium by methods such as PCR and next generation
sequencing could not be performed, as the original blood
specimens had already been discarded by the time such analyses
were considered. The potential for this organism’s misidentiﬁ-
cation through automated and manual, kit-based phenotypic
testing platforms was exempliﬁed in this report, as our isolate
was identiﬁed as E. meningoseptica. In addition, the relatively
recent designation of this genus suggests that Pontibacter spp.
could have been isolated from other human infections in the
past, but was given one or more misnomers. Many biochemical
reactions are consistent with those of E. meningoseptica, but our
isolate is indole negative, a characteristic that can be used to
distinguish our isolate from E. meningoseptica. The data also
highlight the need for conﬁrming unusual identiﬁcations with
additional methods, such as nucleic acid sequencing. This is,
predictably, a relatively common scenario when commercially© 2017 The Authors. Published by Elsevier Ltd on behal
This is an open access articavailable microbial identiﬁcation systems are challenged with
rare and obscure taxa.
To the best of our knowledge, this is the ﬁrst report of broad
antimicrobial susceptibility proﬁling of a Pontibacter isolate.
Although no categorical antimicrobial susceptibility interpretive
guidelines exist for pontibacters, theMICs and zones of inhibition
gleaned from in-depth testing shed some light on the suscepti-
bility of this organism to a variety of antibiotic classes. For
example, these data suggest either acquired or intrinsic resis-
tance to aminoglycosides. This proﬁle is consistent with that of
other members of this genus, which also exhibit resistance to at
least one member of the aminoglycosides [1,2,12]. However,
MICs for most other antibiotics are low, suggesting that this
isolate is susceptible to most routinely used antibiotics.
Ribosomal and phylogenetic analyses indicate that our isolate
represents a novel species, and is appropriately assigned to the
genus Pontibacter. The ribosomal RNA gene sequence and massf of European Society of Clinical Microbiology and Infectious Diseases, NMNI, 19, 71–77
le under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
TABLE 3. Pontibacter species described in the literature are from a wide variety of environmental sources.
Pontibacter species Source Reference
P. amylolyticus Deep-sea hydrothermal vent Wu et al., 2016 [13]
P. actiniarum Marine Nedashkovskaya et al., 2005 [1]
P. akesuensis Desert soil Zhou et al., 2007 [14]
P. chinhatensis Pond sediment containing hexachlorocyclohexane isomer waste Singh et al., 2015 [15]
P. deserti Desert soil Subhash et al., 2014 [16]
P. diazotrophicus Takalamakan desert Xu et al., 2014 [17]
P. humi Mountain soil Srinivasan et al., 2014 [18]
P. indicus Hexachlorocyclohexane-contaminated soil Singh et al., 2014 [19]
P. jeungdoensis Solar saltern Joung et al., 2013 [20]
P. korlensis Desert sand Zhang et al., 2008 [21]
P. locisalis Sy30T Soil from abandoned saltern Zhou et al., 2016 [22]
P. lucknowensis Hexachlorocyclohexane dump site Dwivedi et al., 2013 [23]
P. mucosus Hexachlorocyclohexane-contaminated pond sediment Nayyar et al., 2016 [24]
P. niistensis Forest soil Dastager et al., 2010 [25]
P. odishensis Dry soil of solar saltern Subhash et al., 2013 [26]
P. populi Soil of Euphrates poplar forest Xu et al., 2012 [27]
P. ramchanderi Hexachlorocyclohexane-contaminated pond sediment Singh et al., 2013 [28]
P. rhizosphera Rhizosphere soil of Nerium indicum Raichand et al., 2011 [12]
P. roseus Muddy waters of drainage system Mukherjee et al., 2015 [29]
P. ruber Desert soil Subhash et al., 2014 [16]
P. saemangeumensis Seawater Kang et al., 2013 [30]
P. salisaro Clay tablet solar saltern Joung et al., 2011 [31]
P. toksuensis Arid soil Zhang et al., 2013 [32]
P. ummariensis Hexachlorocyclohexane-contaminated soil Mahato et al., 2015 [33]
P. xinjiangensis Soil Wang et al., 2010 [34]
P. yuliensis Soil of a Populus euphratica forest in the Taklamakan desert Cao et al., 2014 [35]
Pontibacter sp. nov. BAB1700 Drilling well sediments Joshi et al., 2012 [36]
76 New Microbes and New Infections, Volume 19 Number C, September 2017 NMNIspectrum are unique to this organism. Its phylogenetic position
based on 16S ribosomal RNA gene sequence indicates that it is
a relatively divergent member of the genus, though not the
most divergent. Based on these data, we propose the formal
name P. altruii sp. nov., strain Grand Forks after the laboratory
and geographic location of its isolation, respectively.Conclusion and isolate namingDescription of P. altruii sp. nov., strain grand forks
P. altruii sp. nov. (al tru’ i i) N.L. neut. Of Altru Health System
laboratory, the clinical laboratory responsible for recognizing the
novelty of the species. Cells are Gram-negative, rod shaped,
pleomorphic, and move by gliding motility. Aerobic. Non-
sporulating. Chemoorganotroph. Acid is produced from lactose.
Esculin, DNA and gelatin are hydrolysed. Catalase, oxidase and
hydrogen sulphide are produced. Unique 16S rRNA gene
sequence (GenBank Accession no. KX982528) distinct from the
most closely related species in the genus Pontibacter. First isolated
from the blood culture of a woman with sepsis in Grand Forks,
North Dakota, USA. The type strain is Grand Forks.Transparency declarationThe authors have no competing interests to declare. Ethics
approval and consent to participate. Specimens were de-
identiﬁed and so exempted from consent requirements.© 2017 The Authors. Published by Elsevier Ltd on behalf of European Society of Clinical Microb
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/liceAvailability of dataRibosomal RNA sequence has been deposited in GenBank
under the accession number KX982528. P. altruii strain Grand
Forks can be readily obtained by the authors.FundingThis work was supported by internal funds from Altru Health
System, the University of New England College of Osteopathic
Medicine and the Indiana University School of Medicine.Author contributionsMR made the original isolation and performed the phenotypic
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spectrometry, antimicrobial susceptibility testing, biochemical
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